Table 3.
Race/ethnicity, OR [95% CI]
|
|||
---|---|---|---|
Chronic condition | Asian/PI vs. White | Hispanic vs. White | Other vs. White |
Single | |||
1. Hypertension | 2.06 [1.99, 2.13] | 1.65 [1.54, 1.76] | 1.92 [1.83, 2.02] |
2. Hyperlipidemia | 2.21 [2.14, 2.29] | 1.44 [1.35, 1.54] | 1.80 [1.72, 1.89] |
3. Diabetes | 2.19 [2.10, 2.28] | 2.10 [1.95, 2.26] | 2.25 [2.14, 2.38] |
4. Ischemic heart disease | 0.96 [0.92, 1.00] | 0.97 [0.89, 1.05] | 0.95 [0.90, 1.01] |
5. Arthritis | 0.78 [0.74, 0.81] | 0.81 [0.74, 0.88] | 0.80 [0.75, 0.85] |
6. Chronic kidney disease | 1.24 [1.18, 1.29] | 1.44 [1.32, 1.56] | 1.40 [1.32, 1.49] |
7. Alzheimer’s or dementia | 0.89 [0.84, 0.95] | 0.67 [0.59, 0.76] | 0.91 [0.83, 0.99] |
8. Heart failure | 0.85 [0.80, 0.89] | 0.99 [0.89, 1.10] | 1.03 [0.95, 1.11] |
9. Osteoporosis | 1.61 [1.51, 1.71] | 0.92 [0.80, 1.05] | 1.26 [1.15, 1.38] |
10. Cancer | 1.13 [1.07, 1.20] | 0.78 [0.68, 0.89] | 1.16 [1.07, 1.26] |
Dyad | |||
1. Hyperlipidemia–hypertension | 2.26 [2.19, 2.34] | 1.75 [1.64, 1.87] | 1.99 [1.89, 2.08] |
2. Diabetes–hypertension | 2.34 [2.24, 2.44] | 2.23 [2.06, 2.40] | 2.36 [2.23, 2.49] |
3. Diabetes–hyperlipidemia | 2.38 [2.28, 2.49] | 2.18 [2.01, 2.35] | 2.35 [2.22, 2.49] |
4. Hypertension–ischemic heart disease | 1.13 [1.08, 1.18] | 1.14 [1.05, 1.25] | 1.12 [1.05, 1.19] |
5. Hyperlipidemia–ischemic heart disease | 1.15 [1.11, 1.21] | 1.10 [1.00, 1.20] | 1.09 [1.02, 1.16] |
6. Chronic kidney disease–hypertension | 1.35 [1.29, 1.42] | 1.54 [1.41, 1.69] | 1.51 [1.41, 1.62] |
7. Arthritis–hypertension | 0.97 [0.92, 1.02] | 1.07 [0.97, 1.17] | 1.03 [0.96, 1.10] |
8. Arthritis–hyperlipidemia | 1.06 [1.01, 1.11] | 1.04 [0.94, 1.14] | 1.04 [0.97, 1.11] |
9. Chronic kidney disease–hyperlipidemia | 1.40 [1.33, 1.48] | 1.57 [1.42, 1.72] | 1.52 [1.42, 1.64] |
10. Diabetes–ischemic heart disease | 1.57 [1.48, 1.66] | 1.60 [1.44, 1.78] | 1.62 [1.50, 1.75] |
Triad | |||
1. Diabetes–hyperlipidemia–hypertension | 2.42 [2.32, 2.54] | 2.26 [2.09, 2.45] | 2.36 [2.23, 2.51] |
2. Hyperlipidemia–hypertension–ischemic heart disease | 1.23 [1.17, 1.29] | 1.21 [1.11, 1.33] | 1.18 [1.10, 1.26] |
3. Chronic kidney disease– hyperlipidemia–hypertension | 1.55 [1.47, 1.63] | 1.73 [1.57, 1.91] | 1.66 [1.54, 1.78] |
4. Arthritis–hyperlipidemia–hypertension | 1.15 [1.09, 1.21] | 1.19 [1.08, 1.32] | 1.17 [1.09, 1.26] |
5. Diabetes–hypertension–ischemic heart disease | 1.64 [1.55, 1.74] | 1.72 [1.54, 1.92] | 1.68 [1.55, 1.82] |
6. Diabetes–hyperlipidemia–ischemic heart disease | 1.67 [1.57, 1.77] | 1.66 [1.48, 1.86] | 1.67 [1.54, 1.82] |
7. Chronic kidney disease–diabetes– hypertension | 2.00 [1.87, 2.13] | 2.39 [2.13, 2.67] | 2.17 [1.99, 2.37] |
8. Chronic kidney disease–diabetes– hyperlipidemia | 2.02 [1.88, 2.17] | 2.33 [2.07, 2.62] | 2.13 [1.94, 2.33] |
9. Chronic kidney disease– hypertension– ischemic heart disease | 1.23 [1.16, 1.32] | 1.53 [1.35, 1.73] | 1.38 [1.26, 1.52] |
10. Chronic kidney disease–hyperlipidemia– ischemic heart disease | 1.03 [0.97, 1.10] | 1.27 [1.12, 1.45] | 1.21 [1.10, 1.32] |
Note. OR and 95% CI were obtained by multivariable logistic models adjusted for race/ethnicity, age, gender, dual eligibility, and residential area.
The bold-faced values indicate significantly different from Whites. OR = odds ratio; CI = confidence interval; PI = Pacific Islander.